Работы, цитирующие эту работу

Работ: 7

Работа: Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   СтатьяTuberculosis Research and EpidemiologyEurosurveillance2013Цитирований: 15

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

3. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

   Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

   ДругоеTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine2015Цитирований: 1

   ABIABI:AkademIndex/openalex/2015.other.000002

4. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2018Цитирований: 1

   ABIABI:AkademIndex/openalex/2018.article.000181

5. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

6. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   СтатьяTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.article.000040

7. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

   Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

   ДругоеTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.other.000005